![Tikvah Therapeutics, Inc.](/news-release/logo/216797/0/216797.jpg?lastModified=12%2F09%2F2016%2022%3A58%3A52&size=2)
Tikvah Therapeutics Licenses Academia Sinica Patent Estate Related to the Diagnosis, Method of Use, and Treatment of Neurodegenerative Diseases Including Spinal Muscular Atrophy
July 24, 2007 08:00 ET
|
Tikvah Therapeutics, Inc.
ATLANTA, July 24, 2007 (PRIME NEWSWIRE) -- Tikvah Therapeutics, Inc. (Tikvah) and Academia Sinica of Taipei, Taiwan announced today that Tikvah has entered into an exclusive licensing agreement for a...
![Tikvah Therapeutics, Inc.](/news-release/logo/216797/0/216797.jpg?lastModified=12%2F09%2F2016%2022%3A58%3A52&size=2)
Tikvah Therapeutics Enters an Exclusive Licensing Agreement With Apkarian Technologies Related to Agents for Treatment of Pain and Pain-Related Indications
July 16, 2007 13:09 ET
|
Tikvah Therapeutics, Inc.
ATLANTA, July 16, 2007 (PRIME NEWSWIRE) -- Tikvah Therapeutics, Inc. (Tikvah) and Chicago-based Apkarian Technologies, LLC (Apkarian) announced today that Tikvah has entered into an exclusive...
![Tikvah Therapeutics, Inc.](/news-release/logo/216797/0/216797.jpg?lastModified=12%2F09%2F2016%2022%3A58%3A52&size=2)
Tikvah Therapeutics Raises $10 Million Gross Proceeds in Private Financing
July 12, 2007 08:00 ET
|
Tikvah Therapeutics, Inc.
ATLANTA, July 12, 2007 (PRIME NEWSWIRE) -- Tikvah Therapeutics, Inc., a biopharmaceutical company that focuses on novel therapeutic treatments for diseases of the central nervous system, including...